Ionis Pharmaceuticals Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
All right. I want to thank everyone for joining us. So the next company presenting is Ionis Pharmaceuticals. My name is Kevin DeGeeter. I'm a biotech analyst here with Oppenheimer, joined by several of my Oppenheimer colleagues and some of the folks from Ionis.
I think the way we're going to do this is sort of Q&A format. So very much looking forward to that. If you do you have any specific questions, of course, you can e-mail them to me directly. I think most of you have my mail, but [email protected] as well, or I think directly Q&A chat box.
Questions & Answers
With that out of the way, I guess, maybe we'll do a couple of the housekeeping items upfront. Akcea, a very, I think, strategic transaction, the company announced a little over 2 weeks ago now. Just kind of any update you can provide if there is one with regard to time line to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
